CY1112132T1 - ΧΡΗΣΗ ΤΗΣ Ν-(ΔΙΒΕΝΖ(b,f)ΟΞΕΠΙΝ-10-ΥΛΜΕΘΥΛΟ) Ν-ΜΕΘΥΛΟ-Ν-ΠΡΟΠ-2-ΥΝΥΛΑΜΙΝΗΣ (OMIGAPIL) ΓΙΑ ΤΗΝ ΠΡΟΦΥΛΑΞΗ ΚΑΙ/Ή ΤΗΝ ΘΕΡΑΠΕΙΑ ΤΗΣ ΣΥΓΓΕΝΟΥΣ ΜΥΪΚΗΣ ΔΥΣΤΡΟΦΙΑΣ Ή ΜΥΟΠΑΘΕΙΑΣ ΠΟΥ ΕΙΝΑΙ ΑΠΟΤΕΛΕΣΜΑ ΤΗΣ ΑΝΕΠΑΡΚΕΙΑΣ ΚΟΛΛΑΓΟΝΟΥ VI - Google Patents
ΧΡΗΣΗ ΤΗΣ Ν-(ΔΙΒΕΝΖ(b,f)ΟΞΕΠΙΝ-10-ΥΛΜΕΘΥΛΟ) Ν-ΜΕΘΥΛΟ-Ν-ΠΡΟΠ-2-ΥΝΥΛΑΜΙΝΗΣ (OMIGAPIL) ΓΙΑ ΤΗΝ ΠΡΟΦΥΛΑΞΗ ΚΑΙ/Ή ΤΗΝ ΘΕΡΑΠΕΙΑ ΤΗΣ ΣΥΓΓΕΝΟΥΣ ΜΥΪΚΗΣ ΔΥΣΤΡΟΦΙΑΣ Ή ΜΥΟΠΑΘΕΙΑΣ ΠΟΥ ΕΙΝΑΙ ΑΠΟΤΕΛΕΣΜΑ ΤΗΣ ΑΝΕΠΑΡΚΕΙΑΣ ΚΟΛΛΑΓΟΝΟΥ VIInfo
- Publication number
- CY1112132T1 CY1112132T1 CY20111101180T CY111101180T CY1112132T1 CY 1112132 T1 CY1112132 T1 CY 1112132T1 CY 20111101180 T CY20111101180 T CY 20111101180T CY 111101180 T CY111101180 T CY 111101180T CY 1112132 T1 CY1112132 T1 CY 1112132T1
- Authority
- CY
- Cyprus
- Prior art keywords
- prophylaxis
- collagen
- treatment
- resulting
- ynylaminis
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Physical Education & Sports Medicine (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Neurology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pyrane Compounds (AREA)
Abstract
Η εφεύρεση σχετίζεται με την χρήση μιας ένωσης του χημικού τύπου (I) ή ενός φαρμακευτικώς αποδεκτού άλατος προσθήκης αυτής για την παρασκευή ενός φαρμάκου για την προφύλαξη και/ή την θεραπεία μυϊκών δυστροφιών ή μυοπαθειών που είναι αποτέλεσμα μεταλλάξεων σε γονίδια που κωδικοποιούν το κολλαγόνο VI.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP06007217A EP1842539A1 (en) | 2006-04-05 | 2006-04-05 | Use of N- (dibenz(b,f)oxepin-10-ylmethyl)N-methyl-N-prop-2-ynylamine (omigapil) for the prophylaxis and/or treatment of congenital muscular dystrophy or myopathy resulting from collagen VI deficiency |
EP07724008A EP2004176B1 (en) | 2006-04-05 | 2007-04-04 | USE OF N- ( DIBENZ (b, f) OXEPIN-10-YLMETHYL ) N-METHYL-N- PROP- 2 -YNYLAMINE (OMIGAPIL) FOR THE PROPHYLAXIS AND / OR TREATMENT OF CONGENITAL MUSCULAR DYSTROPHY OR MYOPATHY RESULTING FROM COLLAGEN VI DEFICIENCY |
Publications (1)
Publication Number | Publication Date |
---|---|
CY1112132T1 true CY1112132T1 (el) | 2015-11-04 |
Family
ID=36190429
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY20111101180T CY1112132T1 (el) | 2006-04-05 | 2011-11-30 | ΧΡΗΣΗ ΤΗΣ Ν-(ΔΙΒΕΝΖ(b,f)ΟΞΕΠΙΝ-10-ΥΛΜΕΘΥΛΟ) Ν-ΜΕΘΥΛΟ-Ν-ΠΡΟΠ-2-ΥΝΥΛΑΜΙΝΗΣ (OMIGAPIL) ΓΙΑ ΤΗΝ ΠΡΟΦΥΛΑΞΗ ΚΑΙ/Ή ΤΗΝ ΘΕΡΑΠΕΙΑ ΤΗΣ ΣΥΓΓΕΝΟΥΣ ΜΥΪΚΗΣ ΔΥΣΤΡΟΦΙΑΣ Ή ΜΥΟΠΑΘΕΙΑΣ ΠΟΥ ΕΙΝΑΙ ΑΠΟΤΕΛΕΣΜΑ ΤΗΣ ΑΝΕΠΑΡΚΕΙΑΣ ΚΟΛΛΑΓΟΝΟΥ VI |
Country Status (16)
Country | Link |
---|---|
US (1) | US7875648B2 (el) |
EP (2) | EP1842539A1 (el) |
JP (1) | JP4972156B2 (el) |
AT (1) | ATE530181T1 (el) |
AU (1) | AU2007236161B2 (el) |
CA (1) | CA2648155C (el) |
CY (1) | CY1112132T1 (el) |
DK (1) | DK2004176T3 (el) |
ES (1) | ES2371627T3 (el) |
MX (1) | MX2008012867A (el) |
NZ (1) | NZ571129A (el) |
PL (1) | PL2004176T3 (el) |
PT (1) | PT2004176E (el) |
SI (1) | SI2004176T1 (el) |
WO (1) | WO2007115776A1 (el) |
ZA (1) | ZA200807800B (el) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1757284A1 (en) * | 2005-08-25 | 2007-02-28 | Santhera Pharmaceuticals (Schweiz) AG | Use of N-(dibenz(b,f)oxepin-10ylmethyl)-N-methyl-N-prop-2-ynylamine (omigapil) for the prophylaxis and/or treatment of muscular dystrophy |
WO2014120885A1 (en) | 2013-01-30 | 2014-08-07 | The Johns Hopkins University | Treatment of drug abuse by preventing gapdh nitrosylation |
WO2022258629A1 (en) | 2021-06-07 | 2022-12-15 | Katholieke Universiteit Leuven | Idebenone in the treatment of drug resistant epilepsy |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5780244A (en) | 1993-09-27 | 1998-07-14 | La Jolla Cancer Research Foundation | Changes in laminin subunit composition are diagnostic of Fukuyama congenital muscular dystrophy |
US5863743A (en) | 1994-08-12 | 1999-01-26 | University Of Iowa Research Foundation | Merosin deficiency-type congenital muscular dystrophy |
ATE203528T1 (de) | 1995-02-08 | 2001-08-15 | Novartis Erfind Verwalt Gmbh | Antineurodegenerativ wirksame 10-aminoaliphatyl- dibenz- b,f oxepine |
AR008371A1 (es) * | 1996-05-30 | 2000-01-19 | Novartis Ag | Una sal de adicion con acido de una 10-aminoalifatil-dibenz[b,f],oxepina, su empleo; procedimiento para su elaboracion, una 10-aminoalifatil-dibenz[b,f]oxepina, una preparacion farmaceutica que contiene dicha sal o dicha oxepina y un procedimiento para el tratamiento de enfermedades neurodegenerativ |
US7078379B2 (en) | 2002-06-03 | 2006-07-18 | Santhera Pharmaceuticals (Schweiz) Gmbh | Treatment of congenital muscular dystrophies |
EP1589963A1 (en) | 2003-01-29 | 2005-11-02 | Novartis AG | Use of 10-aminoaliphatyl-dibenz b,f oxepines for the tr eatment of degenerative ocular disorders |
PE20050487A1 (es) | 2003-11-06 | 2005-10-07 | Novartis Ag | Composiciones farmaceuticas estabilizadas |
EP1757284A1 (en) * | 2005-08-25 | 2007-02-28 | Santhera Pharmaceuticals (Schweiz) AG | Use of N-(dibenz(b,f)oxepin-10ylmethyl)-N-methyl-N-prop-2-ynylamine (omigapil) for the prophylaxis and/or treatment of muscular dystrophy |
-
2006
- 2006-04-05 EP EP06007217A patent/EP1842539A1/en not_active Withdrawn
-
2007
- 2007-04-04 AU AU2007236161A patent/AU2007236161B2/en not_active Ceased
- 2007-04-04 CA CA2648155A patent/CA2648155C/en not_active Expired - Fee Related
- 2007-04-04 WO PCT/EP2007/003067 patent/WO2007115776A1/en active Application Filing
- 2007-04-04 ES ES07724008T patent/ES2371627T3/es active Active
- 2007-04-04 NZ NZ571129A patent/NZ571129A/en not_active IP Right Cessation
- 2007-04-04 MX MX2008012867A patent/MX2008012867A/es active IP Right Grant
- 2007-04-04 AT AT07724008T patent/ATE530181T1/de active
- 2007-04-04 EP EP07724008A patent/EP2004176B1/en active Active
- 2007-04-04 PT PT07724008T patent/PT2004176E/pt unknown
- 2007-04-04 SI SI200730799T patent/SI2004176T1/sl unknown
- 2007-04-04 PL PL07724008T patent/PL2004176T3/pl unknown
- 2007-04-04 US US12/295,801 patent/US7875648B2/en not_active Expired - Fee Related
- 2007-04-04 DK DK07724008.3T patent/DK2004176T3/da active
- 2007-04-04 JP JP2009503488A patent/JP4972156B2/ja not_active Expired - Fee Related
-
2008
- 2008-09-10 ZA ZA200807800A patent/ZA200807800B/xx unknown
-
2011
- 2011-11-30 CY CY20111101180T patent/CY1112132T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
CA2648155A1 (en) | 2007-10-18 |
PT2004176E (pt) | 2011-11-23 |
NZ571129A (en) | 2011-01-28 |
AU2007236161A1 (en) | 2007-10-18 |
DK2004176T3 (da) | 2012-02-06 |
EP2004176B1 (en) | 2011-10-26 |
JP2009532404A (ja) | 2009-09-10 |
EP2004176A1 (en) | 2008-12-24 |
JP4972156B2 (ja) | 2012-07-11 |
AU2007236161B2 (en) | 2009-12-10 |
US7875648B2 (en) | 2011-01-25 |
MX2008012867A (es) | 2008-10-13 |
WO2007115776A1 (en) | 2007-10-18 |
US20090176867A1 (en) | 2009-07-09 |
PL2004176T3 (pl) | 2012-03-30 |
CA2648155C (en) | 2011-11-15 |
ES2371627T3 (es) | 2012-01-05 |
SI2004176T1 (sl) | 2012-01-31 |
EP1842539A1 (en) | 2007-10-10 |
ATE530181T1 (de) | 2011-11-15 |
ZA200807800B (en) | 2009-06-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA201000050A1 (ru) | Замещенные бициклолактамные соединения | |
CY1112332T1 (el) | Αμινο-ετεροκυκλικες ενωσεις | |
ATE442135T1 (de) | 5ht2c-rezeptor-modulator-zusammensetzungen und anwendungsverfahren | |
CY1110247T1 (el) | Παραγωγα βενζοκιναζολινης και η χρηση τους στην θεραπεια των διαταραχων των οστων | |
TN2009000180A1 (en) | NOVEL 1,4-BENZOTHIEPIN-l,1-DIOXIDE DERIVATIVES WHICH ARE SUBSTITUTED WITH BENZYL GROUPS, METHOD FOR PRODUCING DRUGS CONTAINING SAID COMPOUNDS AND USE THEREOF | |
EA201270505A1 (ru) | Производные иминотиадиазиндиоксида в качестве ингибиторов bace, композиции на их основе, и их применение | |
CY1112311T1 (el) | Ενωσεις πυραζολινης ως ανταγωνιστες υποδοχεα αλατοκορτικοειδους | |
CY1111660T1 (el) | Χρηση παραγωγων θειενοπυριδονης ως ενεργοποιητες αμρκ και φαρμακευτικες συνθεσεις που τις περιεχουν | |
CY1114803T1 (el) | Παραγωγα πυριμιδινο σουλφοναμιδιου ως ρυθμιστες υποδοχεων χημειοκινης | |
CY1110332T1 (el) | Παραγωγα βενζιμιδαζολης, συνθεσεις που τα περιεχουν, παρασκευη αυτων και χρηση τους | |
TW200722081A (en) | New therapeutic combinations for the treatment or prevention of depression | |
CY1114140T1 (el) | Ενωσεις 4-πυριδινονης και η χρηση αυτων για τον καρκινο | |
MX2009001660A (es) | Compuestos de 2,5-dihidroxibenceno para el tratamiento de psoriasis. | |
ATE412636T1 (de) | Piperazinylpyridinderivate als mittel gegen adipositas | |
EA201071006A1 (ru) | Набор, композиция, продукт или лекарственное средство для лечения нарушения познавательной способности | |
TW200626158A (en) | Naphthaline derivatives | |
EA200802173A1 (ru) | Производные терфенила для лечения болезни альцгеймера | |
SE0401342D0 (sv) | Therapeutic compounds | |
EA200702282A1 (ru) | Комбинация феррохина и производного артемизинина для лечения малярии | |
ATE449776T1 (de) | Pyrroloä2,3-cüpyridinderivate | |
MX2009007038A (es) | Derivados de mononitrato de isosorbida para el tratamiento de trastornos intestinales. | |
CY1112132T1 (el) | ΧΡΗΣΗ ΤΗΣ Ν-(ΔΙΒΕΝΖ(b,f)ΟΞΕΠΙΝ-10-ΥΛΜΕΘΥΛΟ) Ν-ΜΕΘΥΛΟ-Ν-ΠΡΟΠ-2-ΥΝΥΛΑΜΙΝΗΣ (OMIGAPIL) ΓΙΑ ΤΗΝ ΠΡΟΦΥΛΑΞΗ ΚΑΙ/Ή ΤΗΝ ΘΕΡΑΠΕΙΑ ΤΗΣ ΣΥΓΓΕΝΟΥΣ ΜΥΪΚΗΣ ΔΥΣΤΡΟΦΙΑΣ Ή ΜΥΟΠΑΘΕΙΑΣ ΠΟΥ ΕΙΝΑΙ ΑΠΟΤΕΛΕΣΜΑ ΤΗΣ ΑΝΕΠΑΡΚΕΙΑΣ ΚΟΛΛΑΓΟΝΟΥ VI | |
TW200806321A (en) | New therapeutic combinations for the treatment or prevention of psychotic disorders | |
IL177169A (en) | Use of n-(2-aryl- propionyl)-sulfonamides for the preparation of medicaments for the treatment of spinal cord injury | |
ATE429910T1 (de) | Chlor enthaltende guanabenz derivate zur behandlung von prionerkrankungen |